Consolidated Statements of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Operating Activities
Net income including noncontrolling interest in subsidiaries	$ 116,459	$ 140,533
Adjustments to Reconcile Net Income to Net Cash Provided by Operating
Amortization of deferred sales commissions	5,999	9,274
Depreciation and other amortization	11,301	16,074
Share-based compensation expense	14,464	14,703
Gain on disposal of assets	(2,443)	(663)
Provision for deferred income taxes	13,470	14,003
Fair-value adjustments for contingent liabilities	900	0
Tax benefit from share-based compensation	128	1,536
Excess tax benefits from share-based compensation	(1,447)	(2,702)
Impairment of assets	0	6,956
Net purchases of trading securities	(7,823)	(3,448)
Deferred sales commissions paid	(6,765)	(8,095)
Contingent deferred sales charges received	1,191	1,761
Proceeds from sale of certain B-share - related future revenue	0	1,223
Other changes in assets and liabilities:
Decrease (increase) in receivables, net	2,495	(885)
Decrease in prepaid expenses and other assets	2,680	14,426
Decrease in accounts payable and accrued expenses	(16,962)	(17,203)
Increase in income taxes payable	1,569	1,079
Increase (decrease) in other liabilities	9,756	(17,581)
Net cash provided by operating activities	144,972	170,991
Investing Activities
Purchases of securities available for sale	(72,108)	(58,202)
Cash paid for business acquisitions	(47,975)	(46,127)
Cash paid for property and equipment	(6,820)	(5,126)
Cash paid for purchased loans	0	(44,343)
Proceeds from disposal of property and equipment	0	3,298
Proceeds from redemptions of securities avaliable for sale	26,795	45,402
Net cash used by investing activities	(100,108)	(105,098)
Financing Activities
Dividends paid	(75,061)	(203,951)
Purchases of treasury stock	(19,867)	(9,289)
Distributions to noncontrolling interests in subsidiaries	(1,521)	(9,670)
Contributions from noncontrolling interests in subsidiaries	6,511	7,467
Proceeds from shareholders for share-based compensation	15,153	683
Excess tax benefits from share-based compensation	1,447	2,702
Proceeds from new borrowings - recourse	0	407,000
Proceeds from new borrowings - nonrecourse	0	271
Payments on debt - recourse	(31,875)	(118,625)
Payments on debt - nonrecourse	(3,775)	(7,383)
Other financing activities	(1,836)	(2,866)
Net cash (used) provided by financing activities	(110,824)	66,339
Net (decrease) increase in cash and cash equivalents	(65,960)	132,232
Cash and cash equivalents, beginning of period	198,756	90,452
Cash and cash equivalents, end of period	$ 132,796	$ 222,684